aspartic acid has been researched along with 6-aminonicotinamide in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 11 (84.62) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colofiore, JR; Koutcher, JA; Martin, DS; Nord, LD; Stolfi, RL | 1 |
| Martin, DS | 1 |
| Colofiore, JR; Martin, DS; Nord, LD; Sternberg, S; Stolfi, RL | 1 |
| Alfieri, AA; Colofiore, JR; Devitt, ML; Koutcher, JA; Martin, DS; Nord, LD; Stolfi, RL | 1 |
| Colofiore, JR; Martin, DS; Nord, LD; Stolfi, RL | 3 |
| Ballon, D; Koutcher, JA; Mahmood, U; Martin, DS; Matei, C; Street, JC | 1 |
| Alfieri, AA; Ballon, D; Koutcher, JA; Martin, DS; Matei, C; Stolfi, RL; Tsai, JC | 1 |
| Martin, DS; Schwartz, GK | 1 |
| Alfieri, AA; Colofiore, JR; Koutcher, JA; Martin, DS; Netto, G; Nord, LD; Reuter, V; Sternberg, SS; Stolfi, RL | 1 |
| Alfieri, AA; Koutcher, JA; Martin, DS; Matei, C; Thaler, H | 1 |
| Gao, S; Hu, J; Liang, Z; Wu, X | 1 |
13 other study(ies) available for aspartic acid and 6-aminonicotinamide
| Article | Year |
|---|---|
Biochemical modulation of tumor cell energy: regression of advanced spontaneous murine breast tumors with a 5-fluorouracil-containing drug combination.
Topics: 6-Aminonicotinamide; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Female; Fluorouracil; Mammary Neoplasms, Experimental; Methylthioinosine; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Orotic Acid; Phosphonoacetic Acid; Phosphoribosyl Pyrophosphate | 1992 |
Cancer chemotherapy: past is prologue.
Topics: 6-Aminonicotinamide; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Female; Fluorouracil; Humans; Male; Mammary Neoplasms, Experimental; Methotrexate; Methylthioinosine; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Phosphonoacetic Acid | 1985 |
Biochemical modulation of tumor cell energy in vivo: II. A lower dose of adriamycin is required and a greater antitumor activity is induced when cellular energy is depressed.
Topics: 6-Aminonicotinamide; Animals; Apoptosis; Aspartic Acid; Dose-Response Relationship, Drug; Doxorubicin; Drug Therapy, Combination; Energy Metabolism; Mammary Neoplasms, Experimental; Methylthioinosine; Phosphonoacetic Acid | 1994 |
Potentiation of a three drug chemotherapy regimen by radiation.
Topics: 6-Aminonicotinamide; Animals; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Combined Modality Therapy; Female; Mercaptopurine; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Neoplasm Transplantation; Neoplasms, Experimental; Phosphonoacetic Acid | 1993 |
Biochemical modulation of tumor cell energy. IV. Evidence for the contribution of adenosine triphosphate (ATP) depletion to chemotherapeutically-induced tumor regression.
Topics: 6-Aminonicotinamide; Adenosine Triphosphate; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Aspartic Acid; Doxorubicin; Mammary Neoplasms, Animal; Methylthioinosine; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Phosphonoacetic Acid; Time Factors | 1995 |
Correlation of retention of tumor methylmercaptopurine riboside-5'-phosphate with effectiveness in CD8F1 murine mammary tumor regression.
Topics: 6-Aminonicotinamide; Adenosine Kinase; Adenosine Triphosphate; Animals; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Mammary Neoplasms, Experimental; Methylthioinosine; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Phosphonoacetic Acid | 1996 |
In vivo detection by 31P NMR of pentose phosphate pathway block secondary to biochemical modulation.
Topics: 6-Aminonicotinamide; Animals; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Cell Division; Magnetic Resonance Spectroscopy; Male; Mammary Neoplasms, Experimental; Methylthioinosine; Mice; Mice, Inbred C3H; Pentose Phosphate Pathway; Phosphonoacetic Acid; Phosphorus; Teratogens | 1996 |
Marked enhancement in vivo of paclitaxel's (taxol's) tumor-regressing activity by ATP-depleting modulation.
Topics: 6-Aminonicotinamide; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Female; Mammary Neoplasms, Experimental; Methylthioinosine; Mice; Paclitaxel; Phosphonoacetic Acid; Remission Induction | 1996 |
Evaluation of chemotherapy and radiation enhancement and 31P NMR spectral changes induced by biochemical modulation.
Topics: 6-Aminonicotinamide; Animals; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Cell Division; Disease Progression; Doxorubicin; Drug Synergism; Evaluation Studies as Topic; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Experimental; Methylthioinosine; Mice; Phosphorus Isotopes; Radiation-Sensitizing Agents | 1997 |
Chemotherapeutically induced DNA damage, ATP depletion, and the apoptotic biochemical cascade.
Topics: 6-Aminonicotinamide; Adenosine Triphosphate; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Aspartic Acid; DNA Damage; Humans; Mercaptopurine; Mice; Phosphonoacetic Acid; Poly(ADP-ribose) Polymerases | 1997 |
Apoptosis induced in advanced CD8F1-murine mammary tumors by the combination of PALA, MMPR and 6AN precedes tumor regression and is preceded by ATP depletion.
Topics: 6-Aminonicotinamide; Adenosine Triphosphate; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Aspartic Acid; Female; Mammary Neoplasms, Experimental; Mercaptopurine; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Phosphonoacetic Acid; Time Factors | 1997 |
Radiation enhancement by biochemical modulation and 5-fluorouracil.
Topics: 6-Aminonicotinamide; Animals; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Cell Division; Combined Modality Therapy; Fluorouracil; Mammary Neoplasms, Animal; Methylthioinosine; Mice; Radiation-Sensitizing Agents; Radiotherapy Dosage; Time Factors | 1997 |
PMA treated THP-1-derived-IL-6 promotes EMT of SW48 through STAT3/ERK-dependent activation of Wnt/β-catenin signaling pathway.
Topics: 6-Aminonicotinamide; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; beta Catenin; Cell Line, Tumor; Cell Movement; Colonic Neoplasms; Epithelial-Mesenchymal Transition; Humans; Interleukin-6; Macrophages; MAP Kinase Signaling System; Methylthioinosine; STAT3 Transcription Factor; THP-1 Cells; Wnt Signaling Pathway | 2018 |